RecruitingNCT04925154

Tradeoffs in Patient Decision Making About Rectal Cancer Treatment: Benefits Compared to Quality Of Life.

PATHOS Tradeoffs in Patient Decision Making About Rectal Cancer Treatment: Benefits Compared to Quality Of Life.


Sponsor

Sir Mortimer B. Davis - Jewish General Hospital

Enrollment

192 participants

Start Date

Dec 13, 2021

Study Type

OBSERVATIONAL

Conditions

Summary

This study is aiming to look into patients' treatment preferences and their socio economic background as well as the exploration of thought processes leading to these preferences. It will integrate, in two exploratory questionnaires, the three most common treatment schema (standard of care, non-operative management, surgery alone) all of which have been demonstrated efficacious.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is exploring how patients with rectal cancer and their doctors make treatment decisions, particularly the tradeoffs between different treatment approaches and quality of life considerations, using online questionnaires. **You may be eligible if (Patient Group):** - You have a new diagnosis of rectal cancer that is operable - You are over 18 years old and capable of giving consent - You can complete online questionnaires in French or English **You may be eligible if (Physician Group):** - You are a treating specialist for rectal cancer - You can complete online questionnaires **You may NOT be eligible if:** - You cannot give your own consent - Your cancer has spread to other organs (metastasis), or it is a recurring tumor (patient group) - You cannot use an online platform to answer questionnaires - You cannot communicate in French or English Talk to your doctor to see if this trial is right for you.

This is a simplified summary. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALThe only intervention will be the information brochure that will be given after the first questionnaire.

The information brochure will be given to both groups at the same time at 2-3 weeks after the first consultation (patients group) or after answering the first questionnaire (physicians group).


Locations(1)

Jewish General Hospital

Montreal, Quebec, Canada

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04925154


Related Trials